Phase II Pilot Controlled Study of Short Vs Longer Term Pimozide (Orap) Therapy in Tourette Syndrome

NCT00004652 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

20

Enrollment

NIH

Sponsor class

Conditions

Tourette Syndrome

Interventions

DRUG: pimozide

Sponsor

National Center for Research Resources (NCRR)

Collaborators

[object Object]